AR and myocardial infarction: FDA statement on SARMs “Body-building products that contain selective androgen receptor modulators, or SARMs, have not been approved by the FDA and are associated with serious safety concerns, including potential to increase the risk of heart attack or stroke and life-threatening reactions like liver damage.” The FDA also notes long-term effects on the body are unknown (31).